What is Xarelto?
Xarelto (rivaroxaban) is a prescription medication that is commonly used to prevent or treat blood clots. It belongs to a class of drugs known as anticoagulants or blood thinners. It was approved by the United States Food and Drug Administration (FDA) in 2011 for various uses.
One of the primary uses of Xarelto is to reduce the risk of stroke and blood clots in people with a medical condition known as atrial fibrillation. It is also used to prevent blood clots in people who have undergone joint replacement surgery , such as knee or hip replacement. Additionally, it is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism.
Xarelto works by blocking the action of a specific protein in the blood known as Factor Xa. This protein is involved in the blood clotting process , and by inhibiting it, Xarelto helps prevent the formation of blood clots.
As with any medication, Xarelto may cause side effects. Common side effects include bleeding, which can sometimes be severe and even life-threatening. Other less common side effects include back pain, headache, and itching. It is important to inform your doctor if you experience any unusual or severe symptoms while taking Xarelto.
In terms of cost, Xarelto can be expensive, but there are assistance programs available to help patients afford the medication. Janssen CarePath is one such program that helps patients navigate the insurance coverage for Xarelto and may also offer financial assistance for eligible patients.
In summary, Xarelto is a prescription medication used to prevent or treat blood clots. While it can be effective, it may also cause side effects, some of which can be severe. It is important to discuss the risks and benefits of taking Xarelto with your doctor, and to inform them of any other medications or health conditions you may have.
Frequently Asked Questions about xarelto
Xarelto® is a blood thinner that treats or prevents blood clots. You may need it if you had a blood clot in your leg or lung. Or you may need it because you have atrial fibrillation but no heart valve issues. Xarelto also prevents clots after surgery to replace your knee or hip.
Xarelto was invented in Bayer's Wuppertal laboratories in Germany, and is being jointly developed by Bayer HealthCare and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
XARELTO® is licensed from Bayer HealthCare AG, 51368 Leverkusen, Germany. Get additional support from Janssen CarePath to help you start and stay on therapy, visit JanssenCarePath.com,or call us.
High-Alert Medicines
Xarelto is a high-alert medicine. This means that Xarelto has been proven to be safe and effective, but serious harm, such as severe bleeding or a stroke, can occur if it is not taken exactly as directed.
Eating grapefruit or drinking grapefruit juice while taking Xarelto could raise the level of the medication in your body. A higher level of Xarelto could increase your risk of side effects from the drug. Your doctor may advise you to avoid eating grapefruit or drinking grapefruit juice during Xarelto treatment.
Xarelto (rivaroxaban) is a medication used to treat and prevent blood clots. The most common side effect of Xarelto is unwanted bleeding. Other side effects include stomach pain, back pain, and itchy skin. Bleeding from Xarelto can be mild or severe.
Xarelto is only available as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
Xarelto, also known as rivaroxaban, is sold in the United States by Johnson & Johnson (JNJ. N) arm Janssen Pharmaceuticals. Eliquis, also known as apixaban, was co-developed by Pfizer Inc (PFE. N) and Bristol Myers Squibb (BMY.
History of Xarelto
Xarelto was first approved for marketing authorization in Canada in September 2008 to prevent venous thromboembolism (VTE) in people who have undergone elective total hip replacement or total knee replacement surgery.
So it's not unusual that the drug increases your risk for bleeding. But it's important to be aware that Xarelto can cause bleeding anywhere in your body, including internal bleeding. Internal bleeding can affect your organs, such as your stomach, lungs, brain, and eyes. Xarelto may cause both mild and severe bleeding.
The typical dosage of Xarelto after hip replacement is 10 mg per day for 35 days. And, the typical dosage after knee replacement is 10 mg per day for 12 days. For these uses, you can take Xarelto with or without food.
If you drink Grapefruit Juice and take Rivaroxaban, your risk of bleeding is increased. Immediately report any unusual bleeding or bruising. Notes for Professionals: Avoid concomitant administration of rivaroxaban and grapefruit juice; significant increases in rivaroxaban exposure may increase bleeding risk.
The typical dosage of Xarelto after hip replacement is 10 mg per day for 35 days. And, the typical dosage after knee replacement is 10 mg per day for 12 days. For these uses, you can take Xarelto with or without food.
Eating grapefruit or drinking grapefruit juice while taking Xarelto could raise the level of the medication in your body. A higher level of Xarelto could increase your risk of side effects from the drug. Your doctor may advise you to avoid eating grapefruit or drinking grapefruit juice during Xarelto treatment.
The cost for Xarelto oral tablet 20 mg is around $581 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Apixaban (Eliquis) users had significantly lower rates of ischemic stroke or systemic embolism than those on rivaroxaban (Xarelto, 6.6 vs 8.0 per 1,000 person-years, HR 0.82, 95% CI 0.68-0.98), according to researchers led by Michael Fralick, MD, PhD, of Brigham and Women's Hospital in Boston, reporting online in the ...